Moreover, blood pre-treatment with the GP IIb/IIIa inhibitor tirofiban (3 μg/mL) showed a trend towards reduction in platelet adhesion to HAEC treated with TNF-α alone or with TNF-α + glucose under flow conditions (Fig. 7 A).
← all excerpts
High glucose enhances inflammation-driven platelet adhesion to endothelial cells in vitro.
1
—
—